Ikenogami
Taku Ikenogami, Takatsuki JP
Patent application number | Description | Published |
---|---|---|
20100331301 | AZETIDINE COMPOUND AND PHARMACEUTICAL USE THEREOF - Compounds of formula [I]: | 12-30-2010 |
Taku Ikenogami, Osaka JP
Patent application number | Description | Published |
---|---|---|
20080255042 | CaSR Antagonist - A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: | 10-16-2008 |
20090326058 | CaSR Antagonist - A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: | 12-31-2009 |
20100158996 | ESTER COMPOUND AND MEDICAL USE THEREOF - A novel therapeutic agent for hyperlipidemia, which is an ester compound represented by the formula (1″) | 06-24-2010 |
20120301552 | CaSR Antagonist - A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof: | 11-29-2012 |
Taku Ikenogami, Takatsuki-Shi, Osaka JP
Patent application number | Description | Published |
---|---|---|
20160137639 | TRIAZOLE-ISOXAZOLE COMPOUND AND MEDICAL USE THEREOF - A compound represented by Formula [I]: | 05-19-2016 |
Toshikatsu Ikenogami, Hyogo JP
Patent application number | Description | Published |
---|---|---|
20090041646 | Catalyst for Removing Oxygen and Method for Removing Oxygen Using the Same Catalyst - Provided is a catalyst for reducing and decomposing oxygen in gas, highly efficiently and stably in from a low temperature region to a relatively high temperature region, in the presence of a reducing substance, containing at least one kind of a metal oxide selected from the group consisting of Ti, Si, W, Mo, Zr and Fe, as a catalyst component A; and at least one kind of a metal selected from the group consisting of Pt, Pd, Rh, Ir, Ru, Ni and Co, and/or a metal oxide thereof, as a catalyst component B; in removing oxygen, presence of a reducing substance in gas is effective. | 02-12-2009 |